The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
The fast-growing nootropics market is set to reach $24.63 billion by 2030. These brain-boosting supplements are becoming more ...
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
News Medical on MSN18h
Advanced brain circuit-mapping technique reveals new anxiety drug targetWeill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...
Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab-irmb) has been approved by the US Food and Drug ...
Verywell Health on MSN1d
New Maintenance Dosing Option for Alzheimer's Drug Leqembi Offers FlexibilityThe Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback